The short answer: probably, at least partly, and the mechanism is better documented than most supplement marketing would have you believe — though not for the reasons the marketing claims. A 2026 systematic review of 25 randomised controlled trials, published in the European Journal of Clinical Nutrition, found consistent improvements in skin hydration and elasticity across the majority of studies. More importantly for the question in the title, the biological pathway connecting what you swallow to what happens in your skin is no longer just a theory — it’s been traced, step by step, in published research.
That doesn’t mean the case is closed. It means the honest answer is more interesting than either “yes, obviously” or “your body just destroys it.”
What 25 trials actually found
The systematic review, led by Christine Bassila and colleagues and published by Nature’s European Journal of Clinical Nutrition in June 2026, pulled together 25 RCTs comparing oral hydrolysed collagen against placebo or active comparators in adults. It covered studies with between 13 and 236 participants each — most in healthy volunteers, seven in people with chronic conditions.
The headline numbers:
- Skin hydration improved in 10 of 15 trials that measured it.
- Skin elasticity improved in 10 of 13 trials.
- Wrinkle depth or volume improved in 9 of 10 trials.
- Transepidermal water loss (how well your skin barrier holds moisture in) was less consistent.
Those are majority-positive results across a meaningful number of independent studies. Not unanimous, not dramatic, but consistent enough to be worth taking seriously.
The mechanism: how collagen gets from your gut to your skin
This is where the real question sits — and where the sceptics have a point that deserves a proper answer.
The standard objection goes like this: collagen is a protein; your body breaks down proteins during digestion; therefore eating collagen is no different from eating chicken or lentils. Your body takes the amino acids and uses them wherever it wants. There’s no reason they’d end up in your skin.
That’s partly right. Your body doesn’t absorb intact collagen molecules and deliver them to your face. But it’s not the whole story.
When hydrolysed collagen is digested, some of it breaks down completely into individual amino acids — the sceptics are right about that. But some fragments survive as small bioactive dipeptides, particularly one called prolyl-hydroxyproline (Pro-Hyp). And these have been tracked through the process:
Step one — they survive digestion and reach your blood. A study published in the Journal of Agricultural and Food Chemistry (Iwai et al., 2005) gave healthy volunteers between 9 and 23 grams of collagen hydrolysate after a 12-hour fast. Pro-Hyp appeared in their blood within one to two hours, peaking at concentrations of 20–60 nanomoles per millilitre of plasma, then falling to half by four hours. It was the most abundant collagen-derived peptide detected.
Step two — they reach skin cells. Rat studies using radiolabelled Pro-Hyp have detected radioactivity in dermal fibroblasts — the cells responsible for producing collagen and other structural proteins in your skin. The distribution wasn’t exclusive to skin (cartilage, bone marrow, and joint tissue also took it up), but skin was clearly on the list.
Step three — they do something when they get there. Research published in the Journal of Dermatology (Ohara et al., 2010) tested Pro-Hyp on cultured human dermal fibroblasts at concentrations matching what’s found in blood after oral collagen intake. At 200 nanomoles per millilitre, fibroblast numbers increased roughly 1.5-fold over six days. More strikingly, hyaluronic acid synthesis — the molecule that holds moisture in your skin — increased approximately 3.8-fold. The mechanism appeared to work through activation of a specific gene (HAS2) involved in hyaluronic acid production.
That’s not proof that a daily jelly stick will transform your skin. The fibroblast work was done in cell cultures, not in living skin, and from a single donor. But it does mean the claim “collagen just gets destroyed like any other protein” is an oversimplification. A specific, documented pathway exists from ingestion to blood to skin cells to a measurable biological response. Whether that pathway produces meaningful visible results at the doses in commercial supplements is exactly where the honest uncertainty sits.
The caveats that matter
The Bassila review’s own authors don’t oversell any of this, and neither should anyone else:
Most studies were rated high risk of bias. The majority of the 25 included trials had methodological issues — many were small, short-term, and funded by supplement manufacturers. The authors assessed risk of bias using the Cochrane RoB 2.0 tool (the gold standard for evaluating trial quality) and flagged this clearly.
The evidence is preliminary. Their own word. They call for “high-quality, standardised, adequately powered, and longer-term RCTs” before the case can be considered settled. That’s the right call — 25 trials showing a consistent signal is meaningful, but it’s not the same as 25 trials proving the point.
Wrinkles are the weakest finding. While 9 of 10 trials showed improvement, a separate 2026 meta-analysis — Batool et al., published in the Journal of Cosmetic Dermatology, covering 35 RCTs and 2,534 participants with actual pooled statistics — found no significant wrinkle benefit after correcting for outliers (pooled effect size −0.06, with a confidence interval crossing zero). Hydration and elasticity held up under that more rigorous analysis. Wrinkle reduction and dermal density did not. Those are the two outcomes supplement marketing leans on hardest, and they’re the two that didn’t survive.
Dose doesn’t seem to matter as much as duration. The Batool meta-analysis found no significant linear relationship between daily dose (ranging from 0.5g to 10g per day across studies) and the size of the benefit. Hydration improvements appeared from around four weeks; elasticity improvements mainly showed at 12 weeks. Consistency over time mattered more than taking a bigger dose.
Two independent reviews, same year, same core message
It’s worth stepping back and noting what happened in 2026: three separate research groups — the Bassila systematic review (25 RCTs), the Batool meta-analysis (35 RCTs), and the ARU umbrella review (113 RCTs via 16 systematic reviews) — all published major analyses of collagen supplementation within months of each other. All three landed on essentially the same conclusion: real but modest benefits for skin hydration and elasticity with consistent use, weaker or absent evidence for wrinkle reduction, and caveats about study quality and industry funding that apply across the board.
That convergence from independent groups using different methods is harder to dismiss than any single study. It’s also not the ringing endorsement the supplement industry might want — “promising but not proven” and “modest improvements that don’t match the marketing” are consistent findings across all three.
What this means for jelly sticks
Nothing about this review changes the format question. A jelly stick delivers collagen peptides the same way a powder, sachet, or capsule does — the Pro-Hyp pathway works (or doesn’t) regardless of how the collagen got into your stomach. What the mechanism evidence does support is the site’s consistent finding that consistency matters more than dose, which is the strongest practical case for whatever format you’ll actually take every day.
The dermatologist piece covers the credible sceptical case against all of this. The evidence roundup has the specific trial data for the peptides used in the products we track. And our where-to-buy guide compares six UK-available options if you’ve weighed this up and want to try one.